Published in Front Cell Infect Microbiol on October 20, 2016
The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci (1992) 44.38
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol (2016) 14.16
"White-opaque transition": a second high-frequency switching system in Candida albicans. J Bacteriol (1987) 7.33
The Saccharomyces cerevisiae zinc finger proteins Msn2p and Msn4p are required for transcriptional induction through the stress response element (STRE). EMBO J (1996) 6.66
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev (1999) 5.51
White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell (2002) 5.36
Candida biofilms and their role in infection. Trends Microbiol (2003) 5.13
Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol (2005) 4.97
Candida infections of medical devices. Clin Microbiol Rev (2004) 4.72
Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev (1997) 4.28
Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev (1998) 4.14
Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science (1999) 4.00
High-frequency switching in Candida albicans. Clin Microbiol Rev (1992) 3.70
brlA is necessary and sufficient to direct conidiophore development in Aspergillus nidulans. Cell (1988) 3.61
Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog (2006) 3.58
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J (2001) 3.48
Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun (1993) 3.41
Opaque-white phenotype transition: a programmed morphological transition in Candida albicans. J Bacteriol (1988) 3.29
Interlocking transcriptional feedback loops control white-opaque switching in Candida albicans. PLoS Biol (2007) 3.27
Emerging opportunistic yeast infections. Lancet Infect Dis (2011) 3.27
Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol (2009) 3.20
Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol (2001) 3.11
Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun (2000) 3.03
Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol (2007) 3.02
Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol (2005) 3.00
A phenotypic profile of the Candida albicans regulatory network. PLoS Genet (2009) 2.86
NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction. EMBO J (2001) 2.76
Epigenetic properties of white-opaque switching in Candida albicans are based on a self-sustaining transcriptional feedback loop. Proc Natl Acad Sci U S A (2006) 2.74
The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol (1996) 2.68
Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol. Biochem Biophys Res Commun (1995) 2.66
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell (2004) 2.61
Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol Biol Cell (2005) 2.56
A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics (2006) 2.54
Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun (1994) 2.41
An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol (2008) 2.34
Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis (2008) 2.33
Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr Genet (1998) 2.32
RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol (2000) 2.30
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell (2007) 2.25
Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol Cell Biol (2001) 2.22
Role of the Hog1 stress-activated protein kinase in the global transcriptional response to stress in the fungal pathogen Candida albicans. Mol Biol Cell (2005) 2.22
A white-specific gene in the white-opaque switching system of Candida albicans. Gene (1993) 2.20
Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis (2002) 2.20
Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun (1999) 2.19
The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosis. PLoS Pathog (2014) 2.19
Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol (2001) 2.18
Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol (2005) 2.15
DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. J Biol Chem (2001) 2.14
The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol (2000) 2.12
A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog (2008) 2.09
Developmental expression of a tandemly repeated, proline-and glutamine-rich amino acid motif on hyphal surfaces on Candida albicans. J Biol Chem (1996) 2.06
Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol Rev (2001) 2.04
Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun (1983) 2.02
Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect Immun (2010) 2.02
Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun (2004) 1.99
Skin facilitates Candida albicans mating. Infect Immun (2003) 1.99
Effect of environmental pH on morphological development of Candida albicans is mediated via the PacC-related transcription factor encoded by PRR2. J Bacteriol (1999) 1.98
Gcn4 co-ordinates morphogenetic and metabolic responses to amino acid starvation in Candida albicans. EMBO J (2002) 1.96
A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog (2007) 1.94
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog (2007) 1.94
HapX-mediated adaption to iron starvation is crucial for virulence of Aspergillus fumigatus. PLoS Pathog (2010) 1.93
Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol Microbiol (2007) 1.93
Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol (2004) 1.91
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol (2008) 1.90
Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun (2003) 1.89
Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell (2004) 1.87
SreA-mediated iron regulation in Aspergillus fumigatus. Mol Microbiol (2008) 1.85
Fungal invasion of normally non-phagocytic host cells. PLoS Pathog (2006) 1.83
UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell (2008) 1.81
N-acetylglucosamine induces white to opaque switching, a mating prerequisite in Candida albicans. PLoS Pathog (2010) 1.81
EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol Microbiol (2003) 1.79
rodletless mutants of Aspergillus fumigatus. Infect Immun (1994) 1.77
Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog (2009) 1.76
The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model. Eukaryot Cell (2007) 1.76
Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Chemother (2005) 1.76
APSES proteins regulate morphogenesis and metabolism in Candida albicans. Mol Biol Cell (2004) 1.74
Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect Immun (1988) 1.71
Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob Agents Chemother (2006) 1.70
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69
Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1. Infect Immun (1990) 1.67
Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol (2006) 1.67
The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol Microbiol (2004) 1.66
Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog (2010) 1.66
Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother (2005) 1.66
Environmental induction of white-opaque switching in Candida albicans. PLoS Pathog (2008) 1.65
Mitochondrial function is required for resistance to oxidative stress in the yeast Saccharomyces cerevisiae. FEBS Lett (1997) 1.64
Fungal biofilms and drug resistance. Emerg Infect Dis (2004) 1.62
The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. Diagn Microbiol Infect Dis (2012) 1.61
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
Induction of germ tube formation by N-acetyl-D-glucosamine in Candida albicans: uptake of inducer and germinative response. J Bacteriol (1982) 1.56
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus. Nat Rev Microbiol (2006) 1.56
Stage specific assessment of Candida albicans phagocytosis by macrophages identifies cell wall composition and morphogenesis as key determinants. PLoS Pathog (2012) 1.54
Differential phagocytosis of white versus opaque Candida albicans by Drosophila and mouse phagocytes. PLoS One (2008) 1.53
The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1. Mol Cell Biol (2001) 1.52
Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood (2004) 1.51
Portrait of Candida albicans adherence regulators. PLoS Pathog (2012) 1.51
The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun (2003) 1.49
SREBP coordinates iron and ergosterol homeostasis to mediate triazole drug and hypoxia responses in the human fungal pathogen Aspergillus fumigatus. PLoS Genet (2011) 1.46
Traversal of Candida albicans across human blood-brain barrier in vitro. Infect Immun (2001) 1.45